Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07947537
NA

Duodenal Mucosa Responses to Endoscopic Food Challenges in Patients With Inflammatory Bowel Disease and Irritable Bowel Syndrome With Self-reported Food Intolerances: A Feasibility Study

Sponsor: McMaster University

View on ClinicalTrials.gov

Summary

The goal of this study is to investigate the feasibility of using intravenous fluorescein during a standard endoscopy-along with a laser to activate it and an optical filter-to identify changes in the duodenal mucosa after a controlled food challenge in individuals with IBD and IBS who experience food intolerances. The main questions it aims to answer are: * Is this technique feasible approach to assess food intolerances in patients with IBD and IBS? * Does patients with IBD and IBS exhibit acute tissue changes upon exposure to specific food antigens? Researches will compare the food antigen to a placebo solution (saline solution without an antigen) to see if the reaction in the tissue is different. Participants will: * Answer questionnaires. * Provide a blood and stool sample. * Take an allergy test. * Undergo an upper endoscopy.

Official title: Duodenal Responses to Food Challenges in Patients With Self-reported Food Intolerances: a Feasibility Study

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

12

Start Date

2027-02-01

Completion Date

2028-03-31

Last Updated

2026-11-19

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

Upper diagnostic endoscopy with food challenges and biopsies

Participants will undergo an upper gastrointestinal endoscopy under conscious sedation. Standard monitoring will be used, and a high-definition video system will record the procedure. A Fuji colonoscope fitted with a transparent distal cap and optical filter will guide the examination up to the proximal jejunum. Upon reaching the duodenum (D3), 5 mL of 10% fluorescein and 40 mg methylscopolamine will be injected intravenously. Immediately after, either a cow's milk protein solution or a placebo solution will be applied to the duodenal mucosa via the endoscope channel. A laser will excite the fluorescein, and real-time video will be recorded. Duodenal fluid (1-1.5 mL) will be collected with an ERCP catheter, and eight biopsies will be obtained for analysis

Locations (1)

McMaster University Medical Centre

Hamilton, Ontario, Canada